Clinical trial
Prophylactic Antimalarial Activity of DB289 in Volunteers
NCT00408369 · Immtech Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00408369 |
|---|---|
| Title | Prophylactic Antimalarial Activity of DB289 in Volunteers |
| Official title | Prophylactic Antimalarial Activity of DB289 in Volunteers Challenged With Plasmodium Falciparum |
| Lead sponsor | Immtech Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prophylactic Activity Against Malaria |
| Intervention type | Drug |
| Interventions | DB289 |
| Enrollment | 19 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Dec 6, 2006 |
| Last update posted | Jan 29, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: